Previous close | 0.0100 |
Open | 0.0150 |
Bid | 0.0100 x 0 |
Ask | 0.0150 x 0 |
Day's range | 0.0150 - 0.0150 |
52-week range | 0.0100 - 0.0350 |
Volume | |
Avg. volume | 56,915 |
Market cap | 2.055M |
Beta (5Y monthly) | -3.58 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, March 04, 2024 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd. (“Vaxil” or the “Company”) (TSXV:VXL) announces that further to press release from January 10, 2024 with Copper Bullet Mines Inc., (“CBMI”), the Company has received a notice of termination of the letter of intent between the Company and CBM
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd. (“Vaxil” or the “Company”) (TSXV:VXL) and Copper Bullet Mines Inc., a corporation existing under the laws of Canada (“CBMI”) are pleased to announce that they have entered into a non-binding letter of intent dated January 9, 2024 (the “LOI”),